Aehr Revenue Triples as AI Orders Pile Up: Rapid Earnings Reaction

Aehr Test Systems reported record fiscal Q1 revenue of $33.0 million, up 200% year over year, and GAAP net income of $7.2 million versus a $0.07-per-share loss a year earlier; shares rose about 17% after hours. Bookings were $46.7 million, lifting backlog above $100 million, and the company raised its fiscal 2027 revenue outlook to $150 million from a prior range of $130 million to $150 million. Cash fell about $11 million since the end of May as the ramp used cash, while a potential major AI-chip-supplier order in Taiwan remains a future watchpoint.

Analysis

The key change is reduced demand uncertainty, not yet proven durable earnings power. Orders and backlog support near-term shipment visibility, but the raised outlook only reaches the prior range’s ceiling; the market may be pricing a broader acceleration than management has committed to. One quarter of strong incremental profit also does not establish a steady margin run rate: mix, utilization, and costs to support the ramp could change as orders ship.

The main second-order risk is working capital. If inventory and receivables keep growing faster than shipments and collections, reported earnings may not translate into self-funded growth. Verify backlog delivery timing, customer concentration, inventory/receivables, and cash conversion before treating the order book as equivalent to revenue. The Taiwan installation is a potential 6–18 month catalyst, but an installation is not a production award; a delayed or absent follow-on order would weaken the AI-demand narrative. Larger test-equipment vendors such as Teradyne and Advantest are sector read-throughs, not assumed one-for-one substitutes; any budget competition depends on the customer’s chosen test architecture.

Near term, the after-hours gap raises the risk/reward hurdle for fresh buyers. Over the next 1–3 months, shipment cadence and cash use matter more than another headline booking figure. The thesis is falsified by backlog slippage, bookings falling below shipments for multiple periods, a guidance reduction, or worsening cash conversion without a clear ramp-related explanation.

Key Decisions for Investors

• Do not chase the post-results gap. For investors seeking exposure, build a staged, modest long only after the initial volatility settles; add only if subsequent results show backlog converting to revenue without a disproportionate deterioration in operating cash flow.
• For existing holders, retain a core position but consider trimming any event-driven excess added into the gap. The upside case is execution against visible demand; the principal downside is that expectations outrun shipment and cash conversion.
• Track quarterly bookings-to-revenue, backlog aging and shipment timing, inventory and receivables growth, and operating cash flow. Treat the Taiwan system as a watch item until a production order and its timing are confirmed.
• Reassess the long thesis if management cuts the fiscal-year outlook, backlog slips materially, or operating cash use worsens alongside rising inventory/receivables; improving cash conversion and confirmed production demand would support adding.